Stock data
Maravai LifeSciences Holdings, Inc. (MRVI)
Maravai LifeSciences Holdings, Inc. (MRVI) reported revenue of US$185.74M and net income of -US$130.77M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$185.74M | US$33.99M | -US$215.27M | -US$130.77M | — |
| 2024 | US$259.19M | US$108.31M | -US$235.62M | -US$144.85M | — |
| 2023 | US$288.94M | US$140.20M | -US$31.65M | -US$119.03M | — |
| 2022 | US$883.00M | — | US$574.22M | US$220.21M | — |
| 2021 | US$799.24M | — | US$554.64M | US$182.04M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$51.44M | -US$12.42M | — |
| 2026-03-31 | US$65.84M | -US$3.73M | — |
| 2025-12-31 | US$49.87M | -US$35.68M | — |
| 2025-09-30 | US$41.63M | -US$25.56M | — |
| 2025-06-30 | US$47.40M | -US$39.59M | — |
| 2025-03-31 | US$46.85M | -US$29.95M | — |
| 2024-12-31 | US$56.56M | -US$25.91M | — |
| 2024-09-30 | US$69.03M | -US$97.07M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.